XML 47 R26.htm IDEA: XBRL DOCUMENT
v3.23.1

Earnings/(Loss) Per Share | 3 Months Ended
--- | ---
Mar. 31, 2023
Earnings Per Share [Abstract] |
Earnings/(Loss) Per Share | 19. Earnings/(Loss) Per Share The following tables set forth reconciliations of the basic and diluted earnings/(loss) per share computations for the periods presented:
|  | Three Months Ended March 31,
Basic Earnings/(Loss) per Share |  | 2023 |  | 2022
Net income/(loss) |  | $ | 16,233 |  |  | $ | (10,261 | )
Less: Income distributed to participating securities |  |  | (498 | ) |  |  | (549 | )
Less: Undistributed income allocable to participating securities |  |  | (1,206 | ) |  |  | — |
Net income/(loss) available to common stockholders—Basic EPS |  | $ | 14,529 |  |  | $ | (10,810 | )
Weighted average common shares (in thousands) |  |  | 143,862 |  |  |  | 142,782 |
Basic earnings/(loss) per share |  | $ | 0.10 |  |  | $ | (0.08 | )
|  | Three Months Ended March 31,
Diluted Earnings/(Loss) per Share |  | 2023 |  | 2022
Net earnings/(loss) available to common stockholders |  | $ | 14,529 |  |  | $ | (10,810 | )
Add back: Undistributed income allocable to participating securities |  |  | 1,206 |  |  |  | — |
Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive |  |  | (1,202 | ) |  |  | — |
Net income/(loss) available to common stockholders—Diluted EPS |  | $ | 14,533 |  |  | $ | (10,810 | )
Weighted Average Diluted Shares (in thousands) : |  |  |  |  |  |  |  |
Weighted average common shares |  |  | 143,862 |  |  |  | 142,782 |
Dilutive effect of common stock equivalents, excluding participating securities |  |  | 569 |  |  |  | — |
Weighted average diluted shares, excluding participating securities (in thousands) |  |  | 144,431 |  |  |  | 142,782 |
Diluted earnings/(loss) per share |  | $ | 0.10 |  |  | $ | (0.08 | )
Diluted earnings/(loss) per share presented above is calculated using the two-class method as this method results in the lowest diluted earnings per share amount for common stock. During the three months ended March 31, 2022, there were no dilutive common stock equivalents as the Company reported a net loss for the period. Total antidilutive non-participating common stock equivalents were 695 and 509 for the three months ended March 31, 2023 and 2022, respectively. There were no potential common shares associated with the conversion options embedded in the Convertible Notes included in weighted average diluted shares for the three months ended March 31, 2023 and 2022 as the Company’s average stock price was lower than the conversion price. The following table reconciles weighted average diluted shares as reported on the Company’s Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022, which are determined pursuant to the treasury stock method, to the weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above:
|  | Three Months Ended March 31,
Reconciliation of Weighted Average Diluted Shares (in thousands) |  | 2023 |  | 2022
Weighted average diluted shares as disclosed on the Consolidated Statements of Operations |  |  | 159,887 |  |  |  | 142,782 | (1)
Less: Participating securities: |  |  |  |  |  |  |  |
Weighted average shares of common stock issuable upon conversion of the Series A Preferred Stock (Note 11) |  |  | (14,750 | ) |  |  | — |
Potentially dilutive restricted stock awards |  |  | (706 | ) |  |  | — |
Weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above |  |  | 144,431 |  |  |  | 142,782 |
(1) | Excludes 15,521 participating securities and 31 potentially dilutive non-participating common stock equivalents for the three months ended March 31, 2022, as the Company reported a net loss for the period (shares herein are reported in thousands).

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration